These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7073530)

  • 41. Impact of the Food and Drug Administration's Public Health Notification on the adoption of drug-eluting stents.
    Curtis JP; Cohen DJ; Jones PG; Bach RG; Spertus JA; Krumholz HM
    Am J Cardiol; 2007 May; 99(9):1227-9. PubMed ID: 17478147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A program to provide regulatory support for investigator-initiated clinical research.
    Arbit HM; Paller MS
    Acad Med; 2006 Feb; 81(2):146-53. PubMed ID: 16436575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Working draft of the FDA GMP final rule (Part II).
    Donawa ME
    Med Device Technol; 1995 Nov; 6(9):9-12. PubMed ID: 10158131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medical device regulations: the Bureau of Medical Devices and the Bureau of Radiological Health.
    Radiol Manage; 1980; 2(4):25-38. PubMed ID: 10247745
    [No Abstract]   [Full Text] [Related]  

  • 45. Guidance for the emergency use of unapproved medical devices; availability--FDA. Notice.
    Fed Regist; 1985 Oct; 50(204):42866-7. PubMed ID: 10274027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medical devices: procedures for investigational device exemptions.
    Fed Regist; 1978 May; 43(93):20725-57. PubMed ID: 10307350
    [No Abstract]   [Full Text] [Related]  

  • 47. Amendment of various device regulations to reflect current American Society for Testing and Material citations. Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 2000 Jan; 65(15):3584-5. PubMed ID: 11010654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Charging for investigational drugs under an investigational new drug application. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The US Food and Drug Administration investigational device exemptions (IDE) and clinical investigation of cardiovascular devices: information for the investigator.
    Pritchard WF; Abel DB; Karanian JW
    J Vasc Surg; 1999 Mar; 29(3):566-74. PubMed ID: 10069924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current regulatory issues in cell and tissue therapy.
    Burger SR
    Cytotherapy; 2003; 5(4):289-98. PubMed ID: 12944234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Food and Drug Administration's import alerts appear to be "misbranded".
    Humphrey CM
    Food Drug Law J; 2003; 58(4):595-612. PubMed ID: 15027452
    [No Abstract]   [Full Text] [Related]  

  • 52. The US Food and Drug Administration investigational device exemptions and clinical investigation of cardiovascular devices: information for the investigator.
    Pritchard WF; Abel DB; Karanian JW
    J Vasc Interv Radiol; 1999 Feb; 10(2 Pt 1):115-22. PubMed ID: 10082096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Food and Drug Administration regulation of spinal implant fixation devices.
    Garfin SR; Yuan HA
    Clin Orthop Relat Res; 1997 Feb; (335):32-8. PubMed ID: 9020204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Technology assessment of medical devices at the Center for Devices and Radiological Health.
    Kessler L; Richter K
    Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical research and the development of new devices: considerations for nurses.
    Lanter J
    Dimens Crit Care Nurs; 2007; 26(3):117-20. PubMed ID: 17440296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(224):64556-88. PubMed ID: 10339052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
    Fed Regist; 1994 Jun; 59(116):31138. PubMed ID: 10136908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Finding value in the U.S. Food and Drug Administration's Fast Track program.
    Reichert JM; Rochon SL; Zhang BD
    Drug News Perspect; 2009; 22(1):53-8. PubMed ID: 19209299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Editorial. Discussion of the Food and Drug Administration's position with respect to certain combinations involving antibiotic drugs.
    J Dist Columbia Dent Soc; 1969 Jul; 44(4):111-2. PubMed ID: 5262515
    [No Abstract]   [Full Text] [Related]  

  • 60. 2004 update--180-day exclusivity under the Hatch-Waxman amendments to the federal Food, Drug, and Cosmetic Act.
    Lietzan EK
    Food Drug Law J; 2004; 59(4):459-63. PubMed ID: 15875350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.